Literature DB >> 26965299

Cognitive reserve and neuropsychological functioning in older HIV-infected people.

Benedetta Milanini1, Nicoletta Ciccarelli2, Massimiliano Fabbiani2, Silio Limiti2, Pierfrancesco Grima3, Barbara Rossetti4, Elena Visconti2, Enrica Tamburrini2, Roberto Cauda2, Simona Di Giambenedetto2.   

Abstract

Progress in treatments has led to HIV+ patients getting older. Age and HIV are risk factors for neurocognitive impairment (NCI). We explored the role of cognitive reserve (CR) on cognition in a group of virologically suppressed older HIV+ people. We performed a multicenter study, consecutively enrolling asymptomatic HIV+ subjects ≥60 years old during routine outpatient visits. A comprehensive neuropsychological battery was administered. Raw test scores were adjusted based on Italian normative data and transformed into z-scores; NCI was defined according to Frascati criteria. All participants underwent the Brief Intelligence Test (TIB) and the Cognitive Reserve Index (CRI) questionnaire as proxies for CR. Relationships between TIB, CRI, and NCI were investigated by logistic or linear regression analyses. Sixty patients (85 % males, median age 66, median education 12, 10 % HCV co-infected, 25 % with past acquired immunodeficiency syndrome (AIDS)-defining events, median CD4 cells count 581 cells/μL, median nadir CD4 cells count 109 cells/μL) were enrolled. Twenty-four patients (40 %) showed Asymptomatic Neurocognitive Impairment. At logistic regression analysis, only CRI (OR 0.94; 95 % CI 0.91-0.97; P = 0.001) and TIB (OR 0.80; 95 % CI 0.71-0.90; P < 0.001) were associated with a lower risk of NCI. Higher CRI and TIB were significantly correlated with a better performance (composite z-score) both globally and at individual cognitive domains. Our findings highlight the role of CR over clinical variables in maintaining cognitive integrity in a virologically suppressed older HIV-infected population. A lifestyle characterized by experiences of mental stimulation may help to cope aging and HIV-related neurodegeneration.

Entities:  

Keywords:  AIDS; Aging; Cognitive reserve; HIV

Mesh:

Substances:

Year:  2016        PMID: 26965299     DOI: 10.1007/s13365-016-0426-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  39 in total

Review 1.  Right hemisphere role in cognitive reserve.

Authors:  Ian H Robertson
Journal:  Neurobiol Aging       Date:  2013-12-04       Impact factor: 4.673

2.  Risk factors for dementia in Parkinson's disease: effect of education.

Authors:  S L Glatt; J P Hubble; K Lyons; A Paolo; A I Tröster; R E Hassanein; W C Koller
Journal:  Neuroepidemiology       Date:  1996 Jan-Feb       Impact factor: 3.282

3.  Neural reserve, neuronal density in the locus ceruleus, and cognitive decline.

Authors:  Robert S Wilson; Sukriti Nag; Patricia A Boyle; Loren P Hizel; Lei Yu; Aron S Buchman; Julie A Schneider; David A Bennett
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

4.  The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.

Authors:  Sapna M Patel; April D Thames; Natalie Arbid; Stella E Panos; Steven Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2013-04-03       Impact factor: 2.475

5.  Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Authors:  Valerio Tozzi; Pietro Balestra; Rita Bellagamba; Angela Corpolongo; Maria Flora Salvatori; Ubaldo Visco-Comandini; Chrysoula Vlassi; Marinella Giulianelli; Simonetta Galgani; Andrea Antinori; Pasquale Narciso
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

Review 6.  Impact of HIV and aging on neuropsychological function.

Authors:  Lauren A Wendelken; Victor Valcour
Journal:  J Neurovirol       Date:  2012-04-14       Impact factor: 2.643

7.  Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data. The Italian Group for the Neuropsychological Study of Ageing.

Authors:  E Capitani; M Laiacona
Journal:  J Clin Exp Neuropsychol       Date:  1997-12       Impact factor: 2.475

8.  Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis.

Authors:  Shelli R Kesler; Heather F Adams; Christine M Blasey; Erin D Bigler
Journal:  Appl Neuropsychol       Date:  2003

9.  Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.

Authors:  V Valcour; C Shikuma; B Shiramizu; M Watters; P Poff; O Selnes; P Holck; J Grove; N Sacktor
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

10.  Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection.

Authors:  R A Stern; S G Silva; N Chaisson; D L Evans
Journal:  Arch Neurol       Date:  1996-02
View more
  12 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

2.  Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Authors:  Karl Goodkin; Eric N Miller; Christopher Cox; Sandra Reynolds; James T Becker; Eileen Martin; Ola A Selnes; David G Ostrow; Ned C Sacktor
Journal:  Lancet HIV       Date:  2017-07-14       Impact factor: 12.767

3.  Sex differences in neurocognitive screening among adults living with HIV in China.

Authors:  Xiaotong Qiao; Haijiang Lin; Xiaoxiao Chen; Chenxi Ning; Keran Wang; Weiwei Shen; Xiaohui Xu; Xiaoyi Xu; Xing Liu; Na He; Yingying Ding
Journal:  J Neurovirol       Date:  2019-02-13       Impact factor: 2.643

4.  Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.

Authors:  Jacqueline Rosenthal; William Tyor
Journal:  J Neurovirol       Date:  2019-03-13       Impact factor: 2.643

5.  Evidence for neuropsychological health disparities in Black Americans with HIV disease.

Authors:  Jennifer L Thompson; Ilex Beltran-Najera; Briana Johnson; Yenifer Morales; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2021-07-10       Impact factor: 3.535

Review 6.  The Impact of Antiretroviral Therapy on Neurocognitive Outcomes Among People Living with HIV in Low- and Middle-Income Countries (LMICs): A Systematic Review.

Authors:  Henry Ukachukwu Michael; Sasha Naidoo; Kofi Boamah Mensah; Suvira Ramlall; Frasia Oosthuizen
Journal:  AIDS Behav       Date:  2021-02

7.  Grit and Ambition are Associated with Better Neurocognitive and Everyday Functioning Among Adults Living with HIV.

Authors:  Raeanne C Moore; Mariam A Hussain; Caitlin W-M Watson; Pariya L Fazeli; María J Marquine; Brandon C Yarns; Dilip V Jeste; David J Moore
Journal:  AIDS Behav       Date:  2018-10

8.  Measuring Cognitive Reserve (CR) - A systematic review of measurement properties of CR questionnaires for the adult population.

Authors:  Nadja Kartschmit; Rafael Mikolajczyk; Torsten Schubert; Maria Elena Lacruz
Journal:  PLoS One       Date:  2019-08-07       Impact factor: 3.240

9.  Cognitive reserve attenuates the association between HIV serostatus and cognitive performance in adults living in the deep South.

Authors:  Caitlin N Pope; Pariya L Fazeli; David E Vance; Sylvie Mrug; Karlene K Ball; Despina Stavrinos
Journal:  Appl Neuropsychol Adult       Date:  2020-10-14       Impact factor: 2.050

10.  Daily Activities Related to Mobile Cognitive Performance in Middle-Aged and Older Adults: An Ecological Momentary Cognitive Assessment Study.

Authors:  Laura M Campbell; Emily W Paolillo; Anne Heaton; Bin Tang; Colin A Depp; Eric Granholm; Robert K Heaton; Joel Swendsen; David J Moore; Raeanne C Moore
Journal:  JMIR Mhealth Uhealth       Date:  2020-09-24       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.